BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/10/2015 10:35:00 AM | Browse: 1270 | Download: 1399
 |
Received |
|
2014-08-19 08:28 |
|
Peer-Review Started |
|
2014-08-20 14:24 |
|
To Make the First Decision |
|
2014-09-27 15:11 |
|
Return for Revision |
|
2014-10-11 16:47 |
|
Revised |
|
2014-10-17 04:54 |
|
Second Decision |
|
2014-12-02 07:36 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-12-16 10:11 |
|
Articles in Press |
|
2014-12-16 10:41 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-03-09 20:01 |
|
Publish the Manuscript Online |
|
2015-03-19 16:57 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Report |
| Article Title |
New therapeutic option for irritable bowel syndrome: Serum derived bovine immunoglobulin
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Larry Good, Roxanne Rosario and Raymond Panas |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Larry Good, MD, Department of Gastroenterology, No. 444 Merrick Road, Lynbrook, NY 11563, United States. good1b@optonline.com |
| Key Words |
Irritable bowel syndrome; Diarrhea; Immunoglobulin; Bovine; Serum derived; Gastrointestinal disease; Medical food |
| Core Tip |
Oral prescription medical foods are becoming part of the outpatient medical practice and are finding new uses as a therapeutic option for gastrointestinal disorders. This case series investigates the use of oral serum-derived bovine immunoglobulin/protein isolate (SBI) in the management of differing forms of irritable bowel syndrome (IBS). Because of the multifaceted mechanism of action, SBI provides a distinct protein source to normalize bowel function, gastrointestinal microbiota, and nutritionally enhance tight junction protein expression. As such, there may be potential use for patients with other forms of IBS besides IBS-D. Additional research is needed to explore this use. |
| Publish Date |
2015-03-19 16:57 |
| Citation |
Good L, Rosario R, Panas R. New therapeutic option for irritable bowel syndrome: Serum-derived bovine immunoglobulin. World J Gastroenterol 2015; 21(11): 3361-3366 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i11/3361.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i11.3361 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
